Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001677006-19-000001
Filing Date
2019-01-22
Accepted
2019-01-22 16:38:28
Documents
1
Effectiveness Date
2019-01-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 5879
  Complete submission text file 0001677006-19-000001.txt   6888
Mailing Address 648 MULFORD ROAD WYNCOTE PA 19095
Business Address 648 MULFORD ROAD WYNCOTE PA 19095 (215) 206-2754
J2 Bio-Pharma, LLC (Filer) CIK: 0001677006 (see all company filings)

EIN.: 812280089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-265309 | Film No.: 19535722